More than 1 billion people are threatened by LF. The disease currently infects over 120 million people, leaving more than 40 million incapacitated or disfigured. More than 95 percent of those at risk live in low-income countries. How can YOU help?

LEARN: LF is considered a Neglected Tropical Disease (NTD), because although it threatens over a billion people worldwide, few people are aware of the disease in countries where people are not at risk. You can help the Global Alliance by learning more about the disease and our many partners working to eliminate it.

TELL: Help us raise awareness about LF by sharing information about the impact of the disease on the poorest populations worldwide. 

GIVE: Donate today by clicking the PayPal Donate button below.  Donations to the Global Alliance go to endemic countries to help fund annual mass drug administration, community education, and treatment of the symptoms of LF (including limb care for elephantiasis and surgeries for hydrocele).  Donations are tax deductible in the United States.

Who can help me?
The Global Alliance to Eliminate LF is a broad partnership that unites national Ministries of Health and more than 40 diverse public and private partners including the World Health Organization, companies within the private sectors, international development agencies and foundations, non-governmental organisations, research institutions, and local communities.

You can help the Global Alliance mobilise political, financial and technical expertise to support the Global Programme to Eliminate LF. Together we can ensure that the Global Alliance achieves its ambitious goal of eliminating LF worldwide by 2020.

What makes the programme affordable?
To reach those in need, the programme relies on the generosity of the Global Alliance partners, including drug donations and community volunteerism.

• GlaxoSmithKline and Merck & Co Inc. are donating drugs (albendazole and Mectizan® [ivermectin]) for as long as necessary to eliminate LF as a public health problem.
• DEC, a generic drug used along with albendazole in LF programmes mostly outside Africa, is extremely affordable.
• Programme costs are shared by external partners and national Ministries of Health, which often cover substantial portions.

Funding is critical to start and scale up country programmes to reach everyone at risk and resources are urgently needed to expand servies for those already infected and support operational research to maximize programme effectiveness.

A lack of care today will deny millions of people the change to lead full and productive lives tomorrow. By clicking on the Donate button above you can join us today and make our vision of a future free of LF a reality.

For further information on the Global Alliance please contact us.